SARS-CoV-2 hijacks neutralizing dimeric IgA for enhanced nasal infection and injury
Zhou, B.; Zhou, R.; Chan, J. F.-W.; Zeng, J.; Zhang, Q.; Yuan, S.; Liu, L.; Robinot, R.; Shan, S.; Ge, J.; Kwong, H. Y.-H.; Zhou, D.; Xu, H.; Chan, C. C.-S.; Poon, V. K.-M.; Chu, H.; Yue, M.; Kwan, K.-Y.; Chan, C.-Y.; Liu, N.; Chan, C. C.-Y.; Chik, K. K.-H.; Du, Z.; Au, K.-K.; Huang, H.; Man, H.-O.; Cao, J.; Li, C.; Wang, Z.; Zhou, J.; Song, Y.; Yeung, M.-L.; To, K. K.-W.; Ho, D. D.; Chakrabarti, L. A.; Wang, X.; Zhang, L.; Yuen, K.-Y.; Chen, Z.
Show abstract
Robust severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in nasal turbinate (NT) accounts for high viral transmissibility, yet whether neutralizing IgA antibodies can control it remains unknown. Here, we evaluated receptor binding domain (RBD)-specific monomeric B8-mIgA1 and B8-mIgA2, and dimeric B8-dIgA1 and B8-dIgA2 against intranasal SARS-CoV-2 challenge in Syrian hamsters. These antibodies exhibited comparably potent neutralization against authentic virus by competing with human angiotensin converting enzyme-2 (ACE2) receptor for RBD binding. While reducing viruses in lungs, pre-exposure intranasal B8-dIgA1 or B8-dIgA2 led to 81-fold more infectious viruses and severer damage in NT than placebo. Virus-bound B8-dIgA1 and B8-dIgA2 could engage CD209 as an alternative receptor for entry into ACE2-negative cells and allowed viral cell-to-cell transmission. Cryo-EM revealed B8 as a class II neutralizing antibody binding trimeric RBDs in 3-up or 2-up/1-down conformation. Therefore, RBD-specific neutralizing dIgA engages an unexpected action for enhanced SARS-CoV-2 nasal infection and injury in Syrian hamsters.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 in vivo 98%
- Characterization of two non-competing antibodies to influenza H3N2 hemagglutinin stem reveals its evolving antigenicity 97%
- Development Of A Potent Monoclonal Antibody For Treatment Of Human Metapneumovirus Infections 97%
Similar papers in this journal
- Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination 97%
- Crimean-Congo Hemorrhagic Fever Survivors Elicit Protective Non-Neutralizing Antibodies that Target 11 Overlapping Regions on Viral Glycoprotein GP38 96%
- Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals 96%
Similar papers in this journal
- Single B cell transcriptomics identifies multiple isotypes of broadly neutralizing antibodies against flaviviruses 98%
- Ethacridine inhibits SARS-CoV-2 by inactivating viral particles in cellular models 96%
- Distinct pathway for evolution of enhanced receptor binding and cell entry in SARS-like bat coronaviruses 96%
Similar papers in this journal
- Identification of a conserved neutralizing epitope present on spike proteins from all highly pathogenic coronaviruses 97%
- Cross-reactive antibodies after SARS-CoV-2 infection and vaccination 97%
- A morphological transformation in respiratory syncytial virus leads to enhanced complement activation 97%
Similar papers in this journal
- Structure and function of a cross-neutralizing influenza neuraminidase antibody that accommodates recent N2 NA Asn245 glycosylation 97%
- Determinants of species-specific utilization of ACE2 by human and animal coronaviruses 97%
- Novel SARS-CoV-2 specific antibody and neutralization assays reveal wide range of humoral immune response during COVID-19 97%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.